Xeris Biopharma Holdings Inc
XERS
Market Cap$285.12M
Close$
$2.89
64.3% upside
Current Fair Value
64.3% upsideUndervalued by 64.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $285.12 Million |
|---|---|
| Enterprise Value | $441.86 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.45 |
| Beta | 1.71 |
| Outstanding Shares | 140,453,467 |
| Avg 30 Day Volume | 1,498,377 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.58 |
|---|---|
| PEG | -128.74 |
| Price to Sales | 1.76 |
| Price to Book Ratio | -1.76 |
| Enterprise Value to Revenue | 2.7 |
| Enterprise Value to EBIT | -10.04 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.52 |
| Debt to Equity | -33.79 |
Revenue Sources
No data
ESG Score
No data
About Xeris Pharmaceuticals Inc
CEO: paul Edick